Cargando…
A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model
Alzheimer's disease (AD) is the most common cause of mental dementia in the aged population. AD is characterized by the progressive decline of memory and multiple cognitive functions, and changes in behavior and personality. Recent research has revealed age‐dependent increased levels of VDAC1 i...
Autores principales: | Vijayan, Murali, Alvir, Rainier Vladlen, Alvir, Razelle Veronique, Bunquin, Lloyd E., Pradeepkiran, Jangampalli Adi, Reddy, P. Hemachandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381918/ https://www.ncbi.nlm.nih.gov/pubmed/35801276 http://dx.doi.org/10.1111/acel.13663 |
Ejemplares similares
-
MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: Relevance to Alzheimer's disease
por: Kumar, Subodh, et al.
Publicado: (2021) -
Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022) -
A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022) -
Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2022) -
Reduced VDAC1, Maintained Mitochondrial Dynamics and Enhanced Mitochondrial Biogenesis in a Transgenic Tau Mouse Model of Alzheimer’s Disease
por: Vijayan, Murali, et al.
Publicado: (2022)